Dexamethasone or Methylprednisolone; Sudden Hearing Loss; Intratympanic Steroid Clinical Trial
Official title:
Intratympanic Dexamethasone or Methylprednisolone for Sudden Hearing Loss as a Salvage Treatment: a Randomized, Double-blind, Multi-center Study
| Verified date | October 2019 |
| Source | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
For patients with sudden hearing loss, the initial treatment is not usually effective. We use Dexamethasone or Methylprednisolone to be an Intratympanic steroid administration as a salvage treatment. An randomized, double-blind, multi-center study is designed to find the difference between Dexamethasone or Methylprednisolone.
| Status | Not yet recruiting |
| Enrollment | 30 |
| Est. completion date | December 31, 2022 |
| Est. primary completion date | December 31, 2021 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: sudden hearing loss and initial treatment is not effective Exclusion Criteria: the patients refused intratympanic steroids treatment. |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | hearing | the hearing level after treatment | six month |